587 Results from the phase 3, double-blind, vehicle-controlled ESSENCE trial of the topical investigational drug SD-101 in epidermolysis bullosa
2018
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI